BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Total Debt Over TimeNormalizing
Percentile Rank71
3Y CAGR-13.7%
5Y CAGR+11.3%
Year-over-Year Change
Sum of short-term and long-term debt obligations
3Y CAGR
-13.7%/yr
vs +86.1%/yr prior
5Y CAGR
+11.3%/yr
Recent deceleration
Acceleration
-99.7pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $477.33M | -43.3% |
| 2024 | $841.42M | +2.0% |
| 2023 | $825.15M | +11.3% |
| 2022 | $741.45M | +25.0% |
| 2021 | $593.24M | +112.2% |
| 2020 | $279.50M | +230.2% |
| 2019 | $84.65M | +36.9% |
| 2018 | $61.82M | +13.0% |
| 2017 | $54.72M | +1.9% |
| 2016 | $53.72M | - |